897 related articles for article (PubMed ID: 34730380)
1. Assessment of the
Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
[TBL] [Abstract][Full Text] [Related]
2.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
3. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
[TBL] [Abstract][Full Text] [Related]
4.
O'Brien B; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
[TBL] [Abstract][Full Text] [Related]
5. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
6. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of nitroxoline against Candida auris isolates.
Fuchs F; Hof H; Hofmann S; Kurzai O; Meis JF; Hamprecht A
Clin Microbiol Infect; 2021 Nov; 27(11):1697.e7-1697.e10. PubMed ID: 34245904
[TBL] [Abstract][Full Text] [Related]
8. Schiff bases of sulphonamides as a new class of antifungal agent against multidrug-resistant Candida auris.
Hamad A; Chen Y; Khan MA; Jamshidi S; Saeed N; Clifford M; Hind C; Sutton JM; Rahman KM
Microbiologyopen; 2021 Aug; 10(4):e1218. PubMed ID: 34459551
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
10. Evaluation of the Vitek 2 system for antifungal susceptibility testing of
Siopi M; Pachoulis I; Leventaki S; Spruijtenburg B; Meis JF; Pournaras S; Vrioni G; Tsakris A; Meletiadis J
J Clin Microbiol; 2024 Apr; 62(4):e0152823. PubMed ID: 38501836
[TBL] [Abstract][Full Text] [Related]
11.
Herrada J; Gamal A; Long L; Sanchez SP; McCormick TS; Ghannoum MA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33846131
[TBL] [Abstract][Full Text] [Related]
12. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
13.
Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
[TBL] [Abstract][Full Text] [Related]
14. The first invasive
Tsai YT; Lu PL; Tang HJ; Huang CH; Hung WC; Tseng YT; Lee KM; Lin SY
Emerg Microbes Infect; 2022 Dec; 11(1):1867-1875. PubMed ID: 35811508
[No Abstract] [Full Text] [Related]
15. Antifungal activity of Caryocar brasiliense camb. Alone or along with antifungal agents against multidrug-resistant Candida auris.
Retore YI; Lucini F; Rial RC; Cardoso CAL; Souza PFN; Simionatto S; Rossato L
J Ethnopharmacol; 2024 Aug; 330():118240. PubMed ID: 38677574
[TBL] [Abstract][Full Text] [Related]
16. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
[TBL] [Abstract][Full Text] [Related]
18. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.
Chow NA; Muñoz JF; Gade L; Berkow EL; Li X; Welsh RM; Forsberg K; Lockhart SR; Adam R; Alanio A; Alastruey-Izquierdo A; Althawadi S; Araúz AB; Ben-Ami R; Bharat A; Calvo B; Desnos-Ollivier M; Escandón P; Gardam D; Gunturu R; Heath CH; Kurzai O; Martin R; Litvintseva AP; Cuomo CA
mBio; 2020 Apr; 11(2):. PubMed ID: 32345637
[No Abstract] [Full Text] [Related]
19. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris
Vazquez JA; Pappas PG; Boffard K; Paruk F; Bien PA; Tawadrous M; Ople E; Wedel P; Oborska I; Hodges MR
Antimicrob Agents Chemother; 2023 May; 67(5):e0141922. PubMed ID: 37022196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
